Titration
See Dose Titration — the staged escalation of a peptide dose from a low starting point to the target therapeutic dose.
Definition
Nearly all peptide protocols include a titration schedule spanning two to four weeks. This approach serves multiple purposes: reducing gastrointestinal symptoms, preventing excessive biomarker increases (such as IGF-1), and enabling clinician adjustments based on individual tolerance before advancing treatment.
Read More
Dose Titration
Gradually increasing a peptide dose from a low starting point — standard practice for GLP-1s, GHRH analogs and any protocol with GI or tolerance profiles.
PeptideGLP-1 Receptor AgonistGLP-1 RA
A peptide drug class that mimics glucagon-like peptide-1 to slow gastric emptying, sharpen insulin response and quiet food-noise.
BiomarkerIGF-1Insulin-like Growth Factor 1
The primary blood marker of growth-hormone activity — the lab that gates any GH-axis protocol and the one re-checked at month 3.
$149 panel.
A clinician reads it in 24 hours.
Order the Peptide Readiness Panel, draw at a Quest or LabCorp near you, and your clinician sends back a matched protocol with a confidence score.